Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2012
08/02/2012US20120196853 Novel Quinoline-Hepcidine Antagonists
08/02/2012US20120196849 Compounds and compositions as hedgehog pathway modulators
08/02/2012US20120196848 Thienooxazepine derivative
08/02/2012US20120196844 Compounds and compositions as modulators of gpr119 activity
08/02/2012US20120196830 Kits and improved compositions for treating lower urinary tract disorders
08/02/2012US20120196829 Method of using beta-hydroxy-beta-methylbutyrate for the prevention and treatment of disease conditions
08/02/2012US20120196812 Pharmaceutical composition, methods for treating and uses thereof
08/02/2012US20120196807 Kidney-targeting drug delivery agent comprising recombinant gelatin
08/02/2012US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
08/02/2012US20120195942 Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints
08/02/2012US20120195939 Parenteral composition comprising microspheres with a diameter between 10 and 20 microns
08/02/2012US20120195902 Compositions and methods for treating renal disease
08/02/2012US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid
08/02/2012US20120195878 Protocol for the administration of botulinum toxins
08/02/2012US20120195876 Novel role of alpha-galactosidase activity as a biomarker in kidney disease
08/02/2012US20120195859 Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (ibd) and irritable bowel syndrome (ibs)
08/02/2012CA2825746A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
08/02/2012CA2825172A1 Indole derivative and pharmacologically acceptable salt of same
08/02/2012CA2825134A1 Indole derivative, and pharmacologically acceptable salt thereof
08/02/2012CA2823781A1 New aryl-benzocycloalkyl amide derivatives
08/01/2012EP2481738A1 Maleic acid salt and crystal thereof
08/01/2012EP2481725A1 Substituted amide compound
08/01/2012EP2188016B1 Use of octreotide as a therapeutic agent
08/01/2012EP2119700B1 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
08/01/2012EP1432407B2 Lisinopril compositions having large-particle dcpd
08/01/2012CN1534010B Water soluble extract of red sage root and its preparation method and use
08/01/2012CN102625808A Spirocyclic amide derivatives
08/01/2012CN102618424A Acanthopanax brachypus life prolonging wine
08/01/2012CN102618420A Health-care liquor and manufacturing method thereof
08/01/2012CN102617734A Antibody Dab-2 against FGF-2 and application thereof
08/01/2012CN102617478A Synthesis of benzimidazole, oxazole and thiazole derivatives and application thereof
08/01/2012CN102617464A fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/01/2012CN102614487A Plaster for treatment of prostate and uracratia
08/01/2012CN102614468A Chinese medicine for treating urinary calculus
08/01/2012CN102614445A Herbal medicine for treating chronic pyelonephritis
08/01/2012CN102614423A Traditional Chinese medical decoction for treatment of chronic kidney disease
08/01/2012CN102614393A Preparation method for traditional Chinese drug for treatment of dampness-heat and stagnation type prostatitis
08/01/2012CN102614295A Food therapy product for protecting prostate and preparation method for food therapy product
08/01/2012CN102614267A Chinese medicinal composition for treating diabetic nephropathy and preparation method thereof
08/01/2012CN102614254A Method for extracting roots of red-rooted salvia
08/01/2012CN102614240A Extract containing breviscapine and preparation method thereof
08/01/2012CN102614218A Crystal unit prepared through healing stone fusion and fusion method thereof
08/01/2012CN102614164A Application of salvianolic acid A in pharmacy
08/01/2012CN102614108A Cubic water quality liquid crystal gel transdermic absorption preparation containing oxybutynin chloride and preparing method thereof
08/01/2012CN102613552A Process for preparing raspberry kidney tonifying sexual function enhancing oral liquid
08/01/2012CN102210682B Application of tetrahydropyrimidine and derivatives thereof in preparing medicament for treating cystitis
07/2012
07/31/2012US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
07/31/2012US8232258 NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and variants thereof, and their use
07/31/2012US8232068 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
07/31/2012CA2465375C 2-aryl-propionic acids and pharmaceutical compositions containing them
07/31/2012CA2458471C Prostaglandin analogs as chloride channel opener
07/26/2012WO2012100228A2 Methods and compositions for treating kidney disorders
07/26/2012WO2012098449A1 Methods for treating disorders that involve immunoglobulin a
07/26/2012WO2012097744A1 Mineralocorticoid receptor antagonists
07/26/2012US20120190743 Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity
07/26/2012US20120190725 Inhibitor(s) of transporters or uptake of monoaminergic neurotransmitters
07/26/2012US20120190716 Methods and uses of cytochrome p450 inhibitors
07/26/2012US20120190701 Renin inhibitors
07/26/2012US20120190654 Novel bicyclic urea compounds
07/26/2012US20120190636 Composition for prophylaxis or treatment of urinary system infection and method thereof
07/26/2012US20120190634 Lipoteichoic acid-derived glycolipids, and compositions comprising same
07/26/2012US20120190625 Novel peptide and use thereof
07/26/2012US20120189717 Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting
07/26/2012US20120189716 Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting
07/26/2012US20120189715 Compositions including beta-hydroxy-beta-methylbutyrate and uses thereof
07/26/2012US20120189714 Compositions including beta-hydroxy-beta-methylbutyrate
07/26/2012US20120189708 Compositions and improved soft tissue replacement methods
07/26/2012US20120189694 Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof
07/26/2012US20120189653 Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient
07/26/2012US20120189626 Treatment of complement-associated disorders
07/26/2012US20120189621 Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists
07/26/2012US20120189604 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
07/26/2012US20120189599 Medication for oral administration, comprising at least one estrogen and/or at least one gestagen and at least one probiotic bacterial strain
07/26/2012US20120189591 Compositions and improved soft tissue replacement methods
07/26/2012US20120189590 Compositions and improved soft tissue replacement methods
07/26/2012US20120189589 Compositions and improved soft tissue replacement methods
07/26/2012US20120189558 Anti-bacterial compositions comprising extracts of eremophila longifolia and methods for use of same
07/26/2012CA2824352A1 Methods and compositions for treating kidney disorders
07/26/2012CA2824344A1 Mineralocorticoid receptor antagonists
07/25/2012EP2477989A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY
07/25/2012EP2477981A1 Heterocyclic mglu5 antagonists
07/25/2012EP2477977A2 Treatment for oxidative stress and/or hypertension
07/25/2012EP2292611B1 Novel thiophenediamine derivative having urea structure
07/25/2012EP1961420B1 Agent for prevention and treatment of acute renal failure
07/25/2012EP1390349B1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
07/25/2012EP1109453B1 Compositions and methods for treatment of mitochondrial diseases
07/25/2012CN102612524A Dual variable domain immunoglobulins and uses thereof
07/25/2012CN102603894A Interferon alpha receptor 1 antibodies and their uses
07/25/2012CN102603734A Protein kinase inhibitor and application thereof
07/25/2012CN102603575A Rhein-arginine eutectic compound, and preparation method, purification method and application thereof in preparation of medicines for treating diabetic complications
07/25/2012CN102600472A Dosage regimen of an s1p receptor agonist
07/25/2012CN102600425A Chinese herba preparation with function of breaking stones and preparation method of Chinese herba preparation
07/25/2012CN102600424A Chinese herba preparation for treating nephropyelitis and preparation method of Chinese herba preparation
07/25/2012CN102600392A Traditional Chinese medicine enema for treating chronic renal failure
07/25/2012CN102600366A Medicament for treating osteoporosis, osteoproliferation and renal failure
07/25/2012CN102600339A Chinese patent medicine of Qianliekangtai capsule for treating prostatitis and preparation method of Qianliekangtai capsule
07/25/2012CN102600219A Total flavone extract of abelmoschus manihot and preparing method of total flavone extract
07/25/2012CN102600166A Application of allopurinol compound in preparing information treatment drug, preparation method and prepared novel drug
07/25/2012CN102600165A Application of compound alfuzosin hydrochloride in preparing information therapy medicines, preparation method thereof and prepared novel medicine
07/25/2012CN102600096A Darifenacin sustained release preparation and preparation method thereof
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 562